These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21830407)

  • 1. Influence of preoperative transarterial chemoembolization on the prognosis for patients with resectable hepatocellular carcinoma: a meta-analysis of randomized trials.
    Wang X; Li J; Peng Y; Dai Y; Xu W
    Hepatogastroenterology; 2011; 58(107-108):869-74. PubMed ID: 21830407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
    Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
    Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
    Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
    Zhou WP; Lai EC; Li AJ; Fu SY; Zhou JP; Pan ZY; Lau WY; Wu MC
    Ann Surg; 2009 Feb; 249(2):195-202. PubMed ID: 19212170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction.
    Kaibori M; Tanigawa N; Matsui Y; Saito T; Uchida Y; Ishizaki M; Tanaka H; Kamiyama Y
    Anticancer Res; 2006; 26(5B):3685-92. PubMed ID: 17094386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
    Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W; Shi J; Xie WF
    Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study of transarterial chemoembolization combined with 3-dimensional conformal radiotherapy for hepatocellular carcinoma.
    Xu LT; Zhou ZH; Lin JH; Chen Z; Wang K; Wang P; Zhu XY; Shen YH; Meng ZQ; Liu LM
    Eur J Surg Oncol; 2011 Mar; 37(3):245-51. PubMed ID: 21195578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP; Yu WS; Wei W
    Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?
    Pérez Saborido B; Meneu JC; Moreno E; García I; Moreno A; Fundora Y
    Am J Surg; 2005 Sep; 190(3):383-7. PubMed ID: 16105523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
    Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS
    Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma].
    Alvarez R; Bañares R; Echenagusía A; Carneros JA; Santos L; Simó G; Camúñez F
    Gastroenterol Hepatol; 2000 Apr; 23(4):153-8. PubMed ID: 10863854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
    Liu Y; Yang R
    J Vasc Interv Radiol; 2009 Apr; 20(4):472-83. PubMed ID: 19250841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
    Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.
    Kim JH; Won HJ; Shin YM; Kim SH; Yoon HK; Sung KB; Kim PN
    Ann Surg Oncol; 2011 Jun; 18(6):1624-9. PubMed ID: 21445671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma.
    Graf H; Jüngst C; Straub G; Dogan S; Hoffmann RT; Jakobs T; Reiser M; Waggershauser T; Helmberger T; Walter A; Walli A; Seidel D; Goke B; Jüngst D
    Digestion; 2008; 78(1):34-8. PubMed ID: 18797167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.